Improving ILD Diagnosis and Predicting Clinical Progression with the Envisia Genomic Classifier

Speakers discuss updated IPF/PPF guidelines, key utility data, and the role of the Envisia Genomic Classifier in the diagnosis and prognosis of ILD. New data is presented that demonstrates how the Envisia Classifier can predict clinical progression in fibrotic ILD.